Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...

The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than ...

The diabetes conference featured a debate about over-the-counter glucose monitors and updates on upcoming devices, including ...

Children exposed to gestational diabetes in utero have an altered hypothalamic response to glucose that leads to higher ...

A 5-day fasting-mimicking diet can help improve blood sugar control in type 2 diabetes, according to a recent clinical trial.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the U.S. and Belgium, was recognized at the American Diabetes Association’s 85th ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

Once-weekly semaglutide improved glycemia and reduced weight in adults with type 1 diabetes and obesity without increasing hypoglycemia.

Semaglutide was associated with improved maximum walking distance across type 2 diabetes subgroups among patients with ...